NDC 50090-6253 – Potassium Chloride
Potassium Chloride 1500 mg/1 · Tablet, Extended Release · Oral
Product NDC50090-6253
Product details
- Brand name
- Potassium Chloride
- Generic name
- Potassium Chloride
- Labeler
- A-S Medication Solutions
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA214422
- Marketed since
- January 20, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Osmotic Laxative; Potassium Salt
Active ingredients
- Potassium Chloride 1500 mg/1
Uses, dosage, side effects and warnings for Potassium Chloride →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 50090-6253-0 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6253-0) | Dec 2, 2022 |
| 50090-6253-1 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6253-1) | Dec 2, 2022 |
| 50090-6253-2 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6253-2) | Dec 2, 2022 |
Other Potassium Chloride products
- 50090-5665 Potassium Chloride 1500 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-6639 Potassium Chloride 750 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-6866 Potassium Chloride 1500 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-6867 Potassium Chloride 1500 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-6640 Potassium Chloride 750 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-7616 Potassium Chloride 1500 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-7456 Potassium Chloride 1500 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-3700 Potassium Chloride 1500 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 62037-720 Potassium Chloride 20 meq/1 · Tablet, Extended Release · Actavis Pharma, Inc.
- 72888-099 Potassium Chloride 1500 mg/1 · Tablet, Extended Release · Advagen Pharma Ltd.
- 72888-098 Potassium Chloride 1125 mg/1 · Tablet, Extended Release · Advagen Pharma Ltd.
- 72888-097 Potassium Chloride 750 mg/1 · Tablet, Extended Release · Advagen Pharma Ltd.